Clinical Trial Update: Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical Trial [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial evaluated rivastigmine for the treatment of postoperative delirium and related cognitive dysfunction, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium
• Postoperative Cognitive Dysfunction

Drugs mentioned

• Exelon (rivastigmine)

Snippet

Sponsor: NYU Langone Health | Conditions: Delirium, Postoperative Cognitive Dysfunction | Phase 4 | Status: COMPLETED | Results posted: 2014-02-13